AbbVie Inc. Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (14 lists). Names and jurisdictions are as filed.
- 2023-02-17: Subsidiary AbbVie Holdco Inc. Delaware.
- 2023-02-17: Subsidiary AbbVie US Holdings LLC Delaware.
- 2023-02-17: Subsidiary Allergan Holdings, Inc. Delaware.
- 2023-02-17: Subsidiary AqueSys, Inc. Delaware.
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2023-02-17 | AbbVie Holdco Inc. Delaware | |
| 2023-02-17 | AbbVie US Holdings LLC Delaware | |
| 2023-02-17 | Allergan Holdings, Inc. Delaware | |
| 2023-02-17 | AqueSys, Inc. Delaware | |
| 2023-02-17 | IEP Pharmaceutical Devices, LLC Delaware | |
| 2023-02-17 | Pioneer Subsidiary LLC Delaware | |
| 2023-02-17 | Warner Chilcott Leasing Equipment Inc. Delaware | |
| 2023-02-17 | AbbVie SA Belgium | |
| 2023-02-17 | AbbVie Farmacêutica Ltda. Brazil | |
| 2023-02-17 | Allergan Medical Device (Shanghai) Co., Ltd. China | |
| 2023-02-17 | Allergan Holdings France SAS France | |
| 2023-02-17 | AbbVie Gyogyszerkereskedelmi Korlatolt | |
| 2023-02-17 | Allergan Pharma Limited Ireland | |
| 2023-02-17 | Aptalis Pharma S.r.l. Italy | |
| 2023-02-17 | Allergan Capital 2 S.à r.l. Luxembourg | |
| 2023-02-17 | Allergan Malta Limited Malta | |
| 2023-02-17 | Aptalis Holding B.V. Netherlands | |
| 2023-02-17 | AbbVie Limited Liability Company Russia | |
| 2023-02-17 | AbbVie Biopharmaceuticals GmbH Switzerland | |
| 2023-02-17 | AbbVie Ltd United Kingdom |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |